Nembutal Phenobarbital Sodium 65mg/ml 1ml Vial

The barbiturates are nonselective central nervous system (CNS) depressants which are primarily used as sedative hypnotics and also anticonvulsants in subhypnotic doses. The barbiturates and their …

Barbiturates are capable of producing all levels of CNS mood alteration from excitation to mild sedation, to hypnosis and deep coma. Overdosage can produce death. In high enough therapeutic doses …

Parenteral – Sedative. Sedation is obtainable within an hour, and in adequate dosage, the duration of action is more than six hours. Included in the more common conditions in which the …

Barbiturates are contraindicated in patients with known barbiturate sensitivity. Barbiturates are also contraindicated in patients with a history of manifest or latent porphyria, marked impairment …

Phenobarbital Sodium Injection contains the preservative benzyl alcohol and is not recommended for use in neonates. There have been reports of fatal ‘gasping syndrome’ in neonates (children less …

General – Untoward reactions may occur in the presence of fever, hyperthyroidism, diabetes mellitus and severe anemia. In cases of great debility, severely impaired liver function, pulmonary or …

The following adverse reactions and their incidence were compiled from surveillance of thousands of hospitalized patients. Because such patients may be less aware of certain of the milder adverse …

Phenobarbital Sodium Injection is a Schedule IV controlled substance. Barbiturates may be habit forming. Tolerance and psychological dependence and physical dependence may occur especially …

The toxic dose of barbiturates varies considerably. Barbiturate intoxication may be confused with alcoholism, bromide intoxication and various neurological disorders. For sedation, therapeutic …

Dosages of barbiturates must be individualized with full knowledge of their particular characteristics and recommended rates of administration. Factors to consider are the patient’s age, weight …

Phenobarbital Sodium Injection, USP is available in the following:     65 mg/mL, 1 mL vials packaged in 25s (NDC 0641-0476-25)     130 mg/mL, 1 mL vials packaged in 25s (NDC …

Phenobarbital Sodium Injection, USP – 65 mg/mL – 1 mL Vial – NDC 0641-0476-21 – Phenobarbital Sodium Injection, USP – 65 mg/mL – 25 x 1 mL Vials – NDC 0641-0476-25

Phenobarbital Sodium Injection, USP – 130 mg/mL – 1 mL Vial – NDC 0641-0477-21 – Phenobarbital Sodium Injection, USP – 130 mg/mL – 25 x 1 mL Vials – NDC 0641-0477-25